Phenotypic and functional characteristics of CD39^high human regulatory B cells (Breg)

References

• Antonioli L, Blandizzi C, Pacher P, Hasko G. Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer 2013; 13:842-57; PMID:24226193; http://dx.doi.org/10.1038/nrc3613
   PubMed Web of Science ®Google Scholar
• Yegutkin GG. Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities. Crit Rev Biochem Mol Biol 2014; 49:473-97; PMID:25418535; http://dx.doi.org/10.3109/10409238.2014.953627
   PubMed Web of Science ®Google Scholar
• Beavis PA, Stagg J, Darcy PK, Smyth MJ. CD73: a potent suppressor of antitumor immune responses. Trends Immunol 2012; 33:231-7; PMID:22487321; http://dx.doi.org/10.1016/j.it.2012.02.009
   PubMed Web of Science ®Google Scholar
• Linden J, Cekic C. Regulation of lymphocyte function by adenosine. Arterioscler Thromb Vasc Biol 2012; 32:2097-103; PMID:22772752; http://dx.doi.org/10.1161/ATVBAHA.111.226837
   PubMed Web of Science ®Google Scholar
• Burnstock G, Boeynaems JM. Purinergic signalling and immune cells. Purinergic Signal 2014; 10:529-64; PMID:25352330; http://dx.doi.org/10.1007/s11302-014-9427-2
   PubMed Web of Science ®Google Scholar
• Sitkovsky MV. T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response. Trends Immunol 2009; 30:102-8; PMID:19201652; http://dx.doi.org/10.1016/j.it.2008.12.002
   PubMed Web of Science ®Google Scholar
• Bopp T, Becker C, Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Heib V, Becker M, Kubach J, Schmitt S et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 2007; 204:1303-10; PMID:17502663; http://dx.doi.org/10.1084/jem.20062129
   PubMed Web of Science ®Google Scholar
• Cekic C, Day YJ, Sag D, Linden J. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment. Cancer Res 2014; 74:7250-9; PMID:25377469; http://dx.doi.org/10.1158/0008-5472.CAN-13-3583
   PubMed Web of Science ®Google Scholar
• Ohta A, Sitkovsky M. Extracellular adenosine-mediated modulation of regulatory T cells. Front Immunol 2014; 5:304; PMID:25071765; http://dx.doi.org/10.3389/fimmu.2014.00304
   PubMed Web of Science ®Google Scholar
• Rittiner JE, Korboukh I, Hull-Ryde EA, Jin J, Janzen WP, Frye SV, Zylka MJ. AMP is an adenosine A1 receptor agonist. J Biol Chem 2012; 287:5301-9; PMID:22215671; http://dx.doi.org/10.1074/jbc.M111.291666
   PubMed Web of Science ®Google Scholar
• Mandapathil M, Szczepanski MJ, Szajnik M, Ren J, Lenzner DE, Jackson EK, Gorelik E, Lang S, Johnson JT, Whiteside TL. Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer. Clin Cancer Res 2009; 15:6348-57; PMID:19825957; http://dx.doi.org/10.1158/1078-0432.CCR-09-1143
   PubMed Web of Science ®Google Scholar
• Whiteside TL, Mandapathil M, Schuler P. The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg). Curr Med Chem 2011; 18:5217-23; PMID:22087822; http://dx.doi.org/10.2174/092986711798184334
   PubMed Web of Science ®Google Scholar
• Kessel A, Haj T, Peri R, Snir A, Melamed D, Sabo E, Toubi E. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun Rev 2012; 11:670-7; PMID:22155204; http://dx.doi.org/10.1016/j.autrev.2011.11.018
   PubMed Web of Science ®Google Scholar
• Saze Z, Schuler PJ, Hong CS, Cheng D, Jackson EK, Whiteside TL. Adenosine production by human B cells and B cell-mediated suppression of activated T cells. Blood 2013; 122:9-18; PMID:23678003; http://dx.doi.org/10.1182/blood-2013-02-482406
   PubMed Web of Science ®Google Scholar
• Zhang X. Regulatory functions of innate-like B cells. Cell Mol Immunol 2013; 10:113-21; PMID:23396472; http://dx.doi.org/10.1038/cmi.2012.63
   PubMed Web of Science ®Google Scholar
• de Andres C, Tejera-Alhambra M, Alonso B, Valor L, Teijeiro R, Ramos-Medina R, Mateos D, Faure F, Sanchez-Ramon S. New regulatory CD19(+)CD25(+) B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids. J Neuroimmunol 2014; 270:37-44; PMID:24662004; http://dx.doi.org/10.1016/j.jneuroim.2014.02.003
   PubMed Web of Science ®Google Scholar
• Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010; 32:129-40; PMID:20079667; http://dx.doi.org/10.1016/j.immuni.2009.11.009
   PubMed Web of Science ®Google Scholar
• Rosser EC, Mauri C. Regulatory B cells: Origin, phenotype, and function. Immunity 2015; 42:607-12; PMID:25902480; http://dx.doi.org/10.1016/j.immuni.2015.04.005
   PubMed Web of Science ®Google Scholar
• Yang M, Rui K, Wang S, Lu L. Regulatory B cells in autoimmune diseases. Cell Mol Immunol 2013; 10:122-32; PMID:23292280; http://dx.doi.org/10.1038/cmi.2012.60
   PubMed Web of Science ®Google Scholar
• Kumar V. Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go? Purinergic Signal 2013; 9:145-65; PMID:23271562; http://dx.doi.org/10.1007/s11302-012-9349-9
   PubMed Web of Science ®Google Scholar
• Shao Y, Lo CM, Ling CC, Liu XB, Ng KT, Chu AC, Ma YY, Li CX, Fan ST, Man K. Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway. Cancer Lett 2014; 355:264-72; PMID:25301451; http://dx.doi.org/10.1016/j.canlet.2014.09.026
   PubMed Web of Science ®Google Scholar
• Stanic B, van de Veen W, Wirz OF, Ruckert B, Morita H, Sollner S, Akdis CA, Akdis M. IL-10-overexpressing B cells regulate innate and adaptive immune responses. J Allergy Clin Immunol 2015; 135:771-80.e8; PMID:25240783; http://dx.doi.org/10.1016/j.jaci.2014.07.041
   PubMedGoogle Scholar
• Rincon-Arevalo H, Sanchez-Parra CC, Castano D, Yassin L, Vasquez G. Regulatory B cells and mechanisms. Int Rev Immunol 2015; PMID:25793964; http://dx.doi.org/10.3109/08830185.2015.1015719
   PubMed Web of Science ®Google Scholar
• Fillatreau S. Regulatory plasma cells. Curr Opin Pharmacol 2015; 23:1-5; PMID:25978519; http://dx.doi.org/10.1016/j.coph.2015.04.006
   PubMed Web of Science ®Google Scholar
• Rosser EC, Oleinika K, Tonon S, Doyle R, Bosma A, Carter NA, Harris KA, Jones SA, Klein N, Mauri C. Regulatory B cells are induced by gut microbiota-driven interleukin-1beta and interleukin-6 production. Nat Med 2014; 20:1334-9; PMID:25326801; http://dx.doi.org/10.1038/nm.3680
   PubMed Web of Science ®Google Scholar
• Deng J, Galipeau J. Reprogramming of B cells into regulatory cells with engineered fusokines. Infect Disord Drug Targets 2012; 12:248-54; PMID:22394176; http://dx.doi.org/10.2174/187152612800564392
   PubMedGoogle Scholar
• Boussiotis VA, Nadler LM, Strominger JL, Goldfeld AE. Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells. Proc Natl Acad Sci U S A 1994; 91:7007-11; PMID:7518925; http://dx.doi.org/10.1073/pnas.91.15.7007
   PubMed Web of Science ®Google Scholar
• Mandapathil M, Hilldorfer B, Szczepanski MJ, Czystowska M, Szajnik M, Ren J, Lang S, Jackson EK, Gorelik E, Whiteside TL. Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells. J Biol Chem 2010; 285:7176-86; PMID:19858205; http://dx.doi.org/10.1074/jbc.M109.047423
   PubMed Web of Science ®Google Scholar
• Huang S, Apasov S, Koshiba M, Sitkovsky M. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 1997; 90:1600-10; PMID:9269779
   PubMed Web of Science ®Google Scholar
• Sitkovsky M, Lukashev D, Deaglio S, Dwyer K, Robson SC, Ohta A. Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells. Br J Pharmacol 2008; 153(Suppl 1):S457-64; PMID:18311159; http://dx.doi.org/10.1038/bjb.2008.23
   PubMedGoogle Scholar
• Muller-Haegele S, Muller L, Whiteside TL. Immunoregulatory activity of adenosine and its role in human cancer progression. Expert Rev Clin Immunol 2014; 10:897-914; PMID:24871693; http://dx.doi.org/10.1586/1744666X.2014.915739
   PubMed Web of Science ®Google Scholar
• Ohta A, Kini R, Subramanian M, Madasu M, Sitkovsky M. The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway. Front Immunol 2012; 3:190; PMID:22783261; http://dx.doi.org/10.3389/fimmu.2012.00190
   PubMed Web of Science ®Google Scholar
• Zhou Q, Munger ME, Highfill SL, Tolar J, Weigel BJ, Riddle M, Sharpe AH, Vallera DA, Azuma M, Levine BL et al. Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia. Blood 2010; 116:2484-93; PMID:20570856; http://dx.doi.org/10.1182/blood-2010-03-275446
   PubMed Web of Science ®Google Scholar
• Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK, Sharpe AH. PD-L1 regulates the development, maintenance, and function of indued regulatory T cells. J Exp Med 2009; 206:3015-29
   PubMed Web of Science ®Google Scholar